1. Risk factors and molecular characterization of penile cancer: impact on prognosis and potential targets for systemic therapy
   Anita Thomas et al, 2020, Current Opinion in Urology CrossRef
2. Nanog, as a key cancer stem cell marker in tumor progression
   Parisa Vasefifar et al, 2022, Gene CrossRef
3. Engrailed-2 promotes a malignant phenotype of esophageal squamous cell carcinoma through upregulating the expression of pro-oncogenic genes
   Yong Cao et al, 2020, PeerJ CrossRef
4. Overexpression of YY1 Regulates the Resistance of Cancer Stem Cells: Targeting YY1
   Benjamin Bonavida, 2019, Cancer Stem Cell Resistance to Targeted Therapy CrossRef
5. Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular Recruitment
   Feng Zhang et al, 2023, Cellular and Molecular Gastroenterology and Hepatology CrossRef
6. Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy
   Mahshid Deldar Abad Paskeh et al, 2022, Life Sciences CrossRef
7. Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapy
   Sepideh Mirzaei et al, 2021, Life Sciences CrossRef
8. METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner
   Jiaoshun Chen et al, 2023, Cancer Letters CrossRef
9. siRNA-mediated silencing of Nanog reduces stemness properties and increases the sensitivity of HepG2 cells to cisplatin
   Hajar Alemohammad et al, 2022, Gene CrossRef
10. Advances in RNAi therapies for gastric cancer: Targeting drug resistance and nanoscale delivery
    Mehrdad Hashemi et al, 2023, Biomedicine & Pharmacotherapy CrossRef
11. Prognostic ability of DNA‑binding protein inhibitor ID‑1 expression in patients with oral squamous cell carcinoma
    Jian Chen et al, 2020, Oncology Letters CrossRef
12. Apigenin Suppresses the Warburg Effect and Stem-like Properties in SOSP-9607 Cells by Inactivating the PI3K/Akt/mTOR Signaling Pathway
    Yihua Shi et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
13. Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
    Roberto Mattioli et al, 2023, Molecular Aspects of Medicine CrossRef
14. Drug Resistance in Cancers: A Free Pass for Bullying
    Jing Li et al, 2022, Cells CrossRef
15. Modulation of Spheroid Forming Capacity and TRAIL Sensitivity by KLF4 and Nanog in Gastric Cancer Cells
    Han Thi Ngoc To et al, 2022, Current Issues in Molecular Biology CrossRef
16. SOX9 promotes epidermal growth factor receptor-tyrosine kinase inhibitor resistance via targeting β-catenin and epithelial to mesenchymal transition in lung cancer
    Surya Kant Tripathi et al, 2021, Life Sciences CrossRef